RFK, Jr. cancels third vaccine planning and scheduling meeting, furthering endangering roll out of annual protective shots

The Food and Drug Administration …  canceled a planned March 13 committee meeting to update next winter’s flu shot.

…

The big picture: Every year, flu vaccine manufacturers depend on the FDA to decide which flu strains to include in the vaccines for Americans.

• The FDA selects these strains based on predictions of which flu variants will spread in the upcoming winter.
• This decision is typically made in early March, following recommendations from the World Health Organization’s experts, who analyze flu data from across the Northern Hemisphere.

The Advisory Committee on Immunization Practices was informed earlier this month that its meeting, originally scheduled for this week, has been postponed. The committee was set to update the nation’s vaccination guidelines for 10 infectious diseases, including COVID-19, mpox and the flu.

A rare disease meeting also got pushed off by HHS this month.

Share this article

XLinkedInFacebookRedditBlueskyThreadsSMSEmail

…

“The abrupt cancellation of the FDA’s next vaccine advisory committee meeting is a deeply concerning development that could delay and disrupt a critical step in production of the annual flu vaccine,” Partnership to Fight Infectious Disease said in a statement.

This is an excerpt. Read the original post here